Combined effect of p53-armed oncolytic virus and immune checkpoint inhibitors in murine pancreatic cancer models

被引:0
|
作者
Fujita, Shuto [1 ]
Tazawa, Hiroshi [1 ,2 ]
Kajiwara, Yoshinori [1 ]
Kikuchi, Satoru [1 ]
Kuroda, Shinji [1 ]
Noma, Kazuhiro [1 ]
Urata, Yasuo [3 ]
Kagawa, Shunsuke [1 ]
Fujiwara, Toshiyoshi [1 ]
机构
[1] Okayama Univ, Grad Sch Med, Dept Surg Gastroenterol, Okayama, Japan
[2] Okayama Univ Hosp, Ctr Innovat Clin Med, Okayama, Japan
[3] Oncolys BioPharma Inc, Tokyo, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P-2182
引用
收藏
页码:961 / 961
页数:1
相关论文
共 46 条
  • [1] p53-Armed Adenoviruses for Gene Virotherapy in Human Pancreatic Cancer
    Perez-Torras, S.
    Urtasun, N.
    Vidal-Pla, A.
    Alemany, R.
    Mazo, A.
    HUMAN GENE THERAPY, 2009, 20 (09) : 1089 - 1089
  • [2] p53-armed oncolytic virotherapy induces abscopal effect in osteosarcoma by promoting immunogenic cell death
    Demiya, Koji
    Tazawa, Hiroshi
    Kondo, Hiroya
    Kure, Miho
    Mochizuki, Yusuke
    Komatsubara, Tadashi
    Yoshida, Aki
    Uotani, Koji
    Hasei, Joe
    Fujiwara, Tomohiro
    Kunisada, Toshiyuki
    Urata, Yasuo
    Kagawa, Shunsuke
    Ozaki, Toshifumi
    Fujiwara, Toshiyoshi
    MOLECULAR THERAPY ONCOLOGY, 2024, 32 (03):
  • [3] Ad-p53-transduced dendritic cell vaccine enhances the efficacy of p53-armed oncolytic virotherapy in colorectal cancer
    Yamada, Motohiko
    Tazawa, Hiroshi
    Shoji, Ryohei
    Nagai, Yasuo
    Inoue, Hiroaki
    Kikuchi, Satoru
    Kuroda, Shinji
    Urata, Yasuo
    Kagawa, Shunsuke
    Fujiwara, Toshiyoshi
    CANCER SCIENCE, 2023, 114 : 1170 - 1170
  • [4] Armed oncolytic myxoma virus demonstrates efficacy in syngeneic tumor models alone and in combination with immune checkpoint inhibitors.
    Franco, Lina S.
    Mamola, Joseph
    Abdullahi, Wazir
    De Matos, Ana
    Abrantes, Mario
    Walker, Benjamin S.
    Tacner, Zachary
    Grigaitis, Nicole
    Kien, Cassandra
    McFadden, Grant
    Sharp, Leslie L.
    CANCER RESEARCH, 2021, 81 (13)
  • [5] p53-armed oncolytic adenovirus induces autophagy and apoptosis in KRAS and BRAF-mutant colorectal cancer cells
    Tamura, Shuta
    Tazawa, Hiroshi
    Hori, Naoto
    Li, Yuncheng
    Yamada, Motohiko
    Kikuchi, Satoru
    Kuroda, Shinji
    Urata, Yasuo
    Kagawa, Shunsuke
    Fujiwara, Toshiyoshi
    PLOS ONE, 2023, 18 (11):
  • [6] Intraperitoneal Administration of p53-armed Oncolytic Adenovirus Inhibits Peritoneal Metastasis of Diffuse-type Gastric Cancer Cells
    Hori, Naoto
    Tazawa, Hiroshi
    Li, Yuncheng
    Okura, Tomohiro
    Kikuchi, Satoru
    Kuroda, Shinji
    Ohara, Toshiaki
    Noma, Kazuhiro
    Nishizaki, Masahiko
    Urata, Yasuo
    Kagawa, Shunsuke
    Fujiwara, Toshiyoshi
    ANTICANCER RESEARCH, 2023, 43 (11) : 4809 - 4821
  • [7] Efficacy of oncolytic herpes virus G47δ combined with immune checkpoint inhibitors in renal cell carcinoma models
    Sasaki, Kenichi
    Takeshima, Yuta
    Iwai, Miwako
    Fukuhara, Hiroshi
    Kume, Haruki
    Todo, Tomoki
    CANCER SCIENCE, 2024, 115 : 648 - 648
  • [8] Efficacy of oncolytic herpes virus G47. combined with immune checkpoint inhibitors in renal cell carcinoma models
    Sasaki, Kenichi
    Takeshima, Yuta
    Iwai, Miwako
    Fukuhara, Hiroshi
    Kume, Haruki
    Todo, Tomoki
    CANCER SCIENCE, 2025, 116 : 1571 - 1571
  • [9] Immune checkpoint inhibitors combined with chemotherapy for the treatment of advanced pancreatic cancer patients
    Ma, Junxun
    Sun, Danyang
    Wang, Jinliang
    Han, Chun
    Qian, Yuanyu
    Chen, Guangying
    Li, Xiaoyan
    Zhang, Juan
    Cui, Pengfei
    Du, Wushuang
    Wu, Zhaozhen
    Chen, Shixue
    Zheng, Xuan
    Yue, Zhichao
    Song, Jia
    Gao, Chan
    Cai, Shangli
    Hu, Yi
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2020, 69 (03) : 365 - 372
  • [10] Immune checkpoint inhibitors combined with chemotherapy for the treatment of advanced pancreatic cancer patients
    Junxun Ma
    Danyang Sun
    Jinliang Wang
    Chun Han
    Yuanyu Qian
    Guangying Chen
    Xiaoyan Li
    Juan Zhang
    Pengfei Cui
    Wushuang Du
    Zhaozhen Wu
    Shixue Chen
    Xuan Zheng
    Zhichao Yue
    Jia Song
    Chan Gao
    Shangli Cai
    Yi Hu
    Cancer Immunology, Immunotherapy, 2020, 69 : 365 - 372